Related references
Note: Only part of the references are listed.IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer
Markus F. Neurath et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2011)
B Cells as a Therapeutic Target for IFN-β in Relapsing-Remitting Multiple Sclerosis
Vinod S. Ramgolam et al.
JOURNAL OF IMMUNOLOGY (2011)
IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease
Jarod Zepp et al.
TRENDS IN IMMUNOLOGY (2011)
Abnormal B-Cell Cytokine Responses A Trigger of T-Cell Mediated Disease in MS?
Amit Bar-Or et al.
ANNALS OF NEUROLOGY (2010)
What are regulatory B cells?
David Gray et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
IL-10 produced by activated human B cells regulates CD4+ T-cell activation in vitro
Jean-David Bouaziz et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis
Mrinalini Kala et al.
EXPERIMENTAL NEUROLOGY (2010)
Signaling via the MyD88 Adaptor Protein in B Cells Suppresses Protective Immunity during Salmonella typhimurium Infection
Patricia Neves et al.
IMMUNITY (2010)
CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients
Paul A. Blair et al.
IMMUNITY (2010)
Suppressive functions of activated B cells in autoimmune diseases reveal the dual roles of Toll-like receptors in immunity
Vicky Lampropoulou et al.
IMMUNOLOGICAL REVIEWS (2010)
TLR and B Cell Receptor Signals to B Cells Differentially Program Primary and Memory Th1 Responses to Salmonella enterica
Tom A. Barr et al.
JOURNAL OF IMMUNOLOGY (2010)
Atacicept: targeting B cells in multiple sclerosis
Hans-Peter Hartung et al.
Therapeutic Advances in Neurological Disorders (2010)
Antibodies Produced by Clonally Expanded Plasma Cells in Multiple Sclerosis Cerebrospinal Fluid
Gregory P. Owens et al.
ANNALS OF NEUROLOGY (2009)
IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice
Stefan Haak et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial
Amit Bar-Or et al.
ANNALS OF NEUROLOGY (2008)
APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells
Elodie Belnoue et al.
BLOOD (2008)
A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses
Koichi Yanaba et al.
IMMUNITY (2008)
Identification of two subpopulations of purified human blood B cells, CD27- CD23+ and CD27high CD80+, that strongly express cell surface Toll-like receptor 9 and secrete high levels of interleukin-6
Fabrice Cognasse et al.
IMMUNOLOGY (2008)
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
Takashi Matsushita et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition
Mark A. Kroenke et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis
Richard A. O'Connor et al.
JOURNAL OF IMMUNOLOGY (2008)
TLR-activated B cells suppress T cell-mediated autoimmunity
Vicky Lampropoulou et al.
JOURNAL OF IMMUNOLOGY (2008)
The genetics of multiple sclerosis: SNPs to pathways to pathogenesis
Jorge R. Oksenberg et al.
NATURE REVIEWS GENETICS (2008)
B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis
Stephen L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis
Satoshi Serada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Activated B cells in autoimmune diseases: the case for a regulatory role
Stephen M. Anderton et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2008)
Not always the bad guys: B cells as regulators of autoimmune pathology
Simon Fillatreau et al.
NATURE REVIEWS IMMUNOLOGY (2008)
TLR-mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells
Tom A. Barr et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis
Martin Duddy et al.
JOURNAL OF IMMUNOLOGY (2007)
B cell regulation of CD4+CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis
Monica K. Mann et al.
JOURNAL OF IMMUNOLOGY (2007)
Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis
Dun Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients
Anne H. Cross et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Kinetics of human B cell behavior and amplification of proliferative responses following stimulation with IL-21
Kim L. Good et al.
JOURNAL OF IMMUNOLOGY (2006)
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis
Yutaka Komiyama et al.
JOURNAL OF IMMUNOLOGY (2006)
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
E Bettelli et al.
NATURE (2006)
B-cell targeting in rheumatoid arthritis and other autoimmune diseases
JCW Edwards et al.
NATURE REVIEWS IMMUNOLOGY (2006)
BCMA is essential for the survival of long-lived bone marrow plasma cells
BP O'Connor et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Prevention of arthritis by interleukin 10-producing B cells
C Mauri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells
C Pasare et al.
SCIENCE (2003)
B cells regulate autoimmunity by provision of IL-10
S Fillatreau et al.
NATURE IMMUNOLOGY (2002)
Blood dendritic cells interact with splenic marginal zone B cells to initiate T-Independent immune responses
M Balázs et al.
IMMUNITY (2002)
Share Paper
